Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/18/1997 | US5688688 Vector for expression of a polypeptide in a mammalian cell |
11/18/1997 | US5688681 Monoclonal antibodies to human leukemia inhibitory factor |
11/18/1997 | US5688678 Induce bone formation; wound healing agents |
11/18/1997 | US5688677 Administering dna for treatment of cystic fibrosis with transmembrane conductance controllers |
11/18/1997 | US5688665 Binding to cyclin dependent kinases; controlling cell reproduction |
11/18/1997 | US5688664 Oligopeptides, polypeptides and sequences |
11/18/1997 | US5688657 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
11/18/1997 | US5688651 Antiagglomerants, monoclonal antibodies, genetic engineered antibody antigens binding fragments and target polypeptides formed by denaturing target polypeptides, mixing, incubation and testing |
11/18/1997 | US5688641 Breast cancer |
11/18/1997 | US5688530 Acromegaly; breast cancer |
11/18/1997 | US5688526 Oxidation resistance |
11/18/1997 | US5688525 Pharmaceutical formulation and process |
11/18/1997 | US5688511 Cellular protein TDP-43 and regulation of HIV-1 gene expression |
11/18/1997 | US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants |
11/18/1997 | US5688505 Method for treating cancer with monoclonal antibodies to oncofetal protein |
11/18/1997 | US5688504 Antagonists |
11/18/1997 | US5688503 Modification of plasminogen activators |
11/18/1997 | US5688502 Digestive enzyme immobilized in gel matrix |
11/18/1997 | US5688499 Antagonism of endothelin actions |
11/13/1997 | WO1997042501A1 Phosphotyrosine mimics and methods for identifying and using same |
11/13/1997 | WO1997042340A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/13/1997 | WO1997042325A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | WO1997042324A1 Use of interleukin-10 to produce a population of suppressor cells |
11/13/1997 | WO1997042322A1 Glycoprotein hormone superagonists |
11/13/1997 | WO1997042321A1 Osteoclast transporter protein |
11/13/1997 | WO1997042319A1 NOVEL Fas ANTIGEN DERIVATIVES |
11/13/1997 | WO1997042318A1 Vaccines |
11/13/1997 | WO1997042317A1 APTAMERS FOR COMPLEMENT PROTEIN C3b |
11/13/1997 | WO1997042313A1 Transgenic plants expressing assembled secretory antibodies |
11/13/1997 | WO1997042309A1 TRANSGENIC ANIMALS DEFICIENT IN ENDOGENOUS β3-ADRENERGIC RECEPTOR AND USES THEREOF |
11/13/1997 | WO1997042224A1 Neurotactin and uses therefor |
11/13/1997 | WO1997042223A1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
11/13/1997 | WO1997042222A1 Methods and means for inhibition of cdk4 activity |
11/13/1997 | WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
11/13/1997 | WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042217A1 Radiolabeled fusion toxins for cancer therapy |
11/13/1997 | WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042212A1 Sok-1 and methods of use |
11/13/1997 | WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
11/13/1997 | WO1997042209A1 Human rad |
11/13/1997 | WO1997041899A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
11/13/1997 | WO1997041898A1 Targeted combination immunotherapy of cancer |
11/13/1997 | WO1997041895A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
11/13/1997 | WO1997041887A1 Treatment of partial growth hormone insensitivity syndrome |
11/13/1997 | WO1997041886A1 Stimulation of host defence mechanisms against tumors |
11/13/1997 | WO1997041885A1 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets |
11/13/1997 | WO1997041884A1 Method of treatment |
11/13/1997 | WO1997041883A1 Stimulation of host defense mechanisms against viral challenges |
11/13/1997 | WO1997041882A1 Method for treating inflammation |
11/13/1997 | WO1997041881A1 Morphogen treatment for chronic renal failure |
11/13/1997 | WO1997041880A1 Therapies for chronic renal failure |
11/13/1997 | WO1997041879A1 Enhancement of sleep with a growth hormone secretagogue |
11/13/1997 | WO1997041878A1 Treatment of mood disorders with a growth hormone secretagogue |
11/13/1997 | WO1997041863A1 Mixed chimerism and tolerance |
11/13/1997 | WO1997041854A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
11/13/1997 | WO1997041849A1 Anti-viral method |
11/13/1997 | WO1997041833A1 Dispersible macromolecule compositions and methods for their preparation and use |
11/13/1997 | WO1997041831A1 Stimulation of immune response with low doses of il-2 |
11/13/1997 | WO1997041824A2 Antiangiogenic peptides derived from plasminogen |
11/13/1997 | WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence |
11/13/1997 | WO1997033996A3 Human bikunin |
11/13/1997 | WO1997032607A3 Activated linkers and methods for making and purifying the same |
11/13/1997 | WO1997032020A3 Shc proteins |
11/13/1997 | WO1997031611A3 Treatment of begnin prostatic hyperplasia |
11/13/1997 | WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
11/13/1997 | WO1997025032A3 Monoglyceride compositions and their use against helicobacter |
11/13/1997 | WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds |
11/13/1997 | DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance |
11/13/1997 | CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions |
11/13/1997 | CA2253908A1 Stimulation of host defence mechanisms against tumors |
11/13/1997 | CA2253904A1 Targeted combination immunotherapy of cancer |
11/13/1997 | CA2253902A1 Stimulation of host defense mechanisms against viral challenges |
11/13/1997 | CA2253864A1 Neurotactin and uses therefor |
11/13/1997 | CA2253834A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | CA2253832A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | CA2253803A1 Use of interleukin-10 to produce a population of suppressor cells |
11/13/1997 | CA2253776A1 Phosphotyrosine mimics and methods for identifying and using same |
11/13/1997 | CA2253743A1 Anti-viral method |
11/13/1997 | CA2253597A1 Mixed chimerism and tolerance |
11/13/1997 | CA2253557A1 Treatment of asthma with tnfr-ig |
11/13/1997 | CA2253494A1 Novel fas antigen derivative |
11/13/1997 | CA2253454A1 Transgenic plants expressing assembled secretory antibodies |
11/13/1997 | CA2253441A1 Glycoprotein hormone superagonists |
11/13/1997 | CA2253390A1 Enhancement of sleep with a growth hormone secretagogue |
11/13/1997 | CA2253312A1 Method for treating inflammation |
11/13/1997 | CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
11/13/1997 | CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/12/1997 | EP0806477A1 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna |
11/12/1997 | EP0806432A1 Glutathione monoester sulfonate |
11/12/1997 | EP0806203A2 Anti-viral compositions |
11/12/1997 | EP0805871A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
11/12/1997 | EP0805869A2 Direct gene transfer into the ruminant mammary gland |
11/12/1997 | EP0805863A2 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON |
11/12/1997 | EP0805862A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
11/12/1997 | EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
11/12/1997 | EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides |
11/12/1997 | EP0805853A1 Lineage-directed induction of human mesenchymal stem cell differentiation |
11/12/1997 | EP0805822A1 Spray dried erythropoietin |
11/12/1997 | EP0805820A1 Ligands for eph-like receptors |